| |
Last Name |
First Name |
Research/Clinical Interest Title |
Keywords |
 |
FRANK |
STUART |
Growth Hormone Action and GH Receptor Structure and Function |
growth hormone, signaling, prolactin, IGF-1, growth factors |
 |
FRANK |
STUART |
Growth Hormone Action and GH Receptor Structure and Function |
growth hormone, signaling, prolactin, IGF-1, growth factors |
 |
FRANK |
STUART |
Growth Hormone Action and GH Receptor Structure and Function |
growth hormone, signaling, prolactin, IGF-1, growth factors |
 |
FRANK |
STUART |
Growth Hormone Action and GH Receptor Structure and Function |
growth hormone, signaling, prolactin, IGF-1, growth factors |
 |
FRANK |
STUART |
Growth Hormone Action and GH Receptor Structure and Function |
growth hormone, signaling, prolactin, IGF-1, growth factors |
 |
FRANK |
STUART |
Growth Hormone Action and GH Receptor Structure and Function |
growth hormone, signaling, prolactin, IGF-1, growth factors |
 |
FRANK |
STUART |
Growth Hormone Action and GH Receptor Structure and Function |
growth hormone, signaling, prolactin, IGF-1, growth factors |
 |
FRANK |
STUART |
Growth Hormone Action and GH Receptor Structure and Function |
growth hormone, signaling, prolactin, IGF-1, growth factors |
 |
FRANK |
STUART |
Growth Hormone Action and GH Receptor Structure and Function |
growth hormone, signaling, prolactin, IGF-1, growth factors |
 |
FRANK |
STUART |
Growth Hormone Action and GH Receptor Structure and Function |
growth hormone, signaling, prolactin, IGF-1, growth factors |
 |
FRANK |
STUART |
Growth Hormone Action and GH Receptor Structure and Function |
growth hormone, signaling, prolactin, IGF-1, growth factors |
 |
FRANK |
STUART |
Growth Hormone Action and GH Receptor Structure and Function |
growth hormone, signaling, prolactin, IGF-1, growth factors |
 |
FRANK |
STUART |
Growth Hormone Action and GH Receptor Structure and Function |
growth hormone, signaling, prolactin, IGF-1, growth factors |
 |
FRIEDMAN |
GREGORY |
|
pediatric neuro-oncology, immunotherapy, oncolytic virotherapy, gene therapy, engineered herpes simplex virus (HSV) |
 |
FRIEDMAN |
GREGORY |
|
pediatric neuro-oncology, immunotherapy, oncolytic virotherapy, gene therapy, engineered herpes simplex virus (HSV) |
 |
FUJIHASHI |
KOHTARO |
The Cellular and Molecular Mechanisms for Mucosal Immunity in the Elderly; Molecular and Cellular Mechanisms for the Induction and Regulation of Mucosally Induced Tolerance; A Mucosal Internet Of gd, ab T Cells and Epithelial Cells for Mucosal Immunity; Mucosal Immunity in Murine Models of IBD
|
Mucosal Immunology, Oral Tolerance, Salivary IgA Antibody |
 |
FUJIHASHI |
KOHTARO |
The Cellular and Molecular Mechanisms for Mucosal Immunity in the Elderly; Molecular and Cellular Mechanisms for the Induction and Regulation of Mucosally Induced Tolerance; A Mucosal Internet Of gd, ab T Cells and Epithelial Cells for Mucosal Immunity; Mucosal Immunity in Murine Models of IBD
|
Mucosal Immunology, Oral Tolerance, Salivary IgA Antibody |
 |
FUJIHASHI |
KOHTARO |
The Cellular and Molecular Mechanisms for Mucosal Immunity in the Elderly; Molecular and Cellular Mechanisms for the Induction and Regulation of Mucosally Induced Tolerance; A Mucosal Internet Of gd, ab T Cells and Epithelial Cells for Mucosal Immunity; Mucosal Immunity in Murine Models of IBD
|
Mucosal Immunology, Oral Tolerance, Salivary IgA Antibody |
 |
FULLER |
CATHERINE |
ENaC/ASIC Ion Channels; |
Sodium channels, glioma, migration, proliferation, cancer, signaling, polycystic kidney disease |
 |
FULLER |
CATHERINE |
ENaC/ASIC Ion Channels; |
Sodium channels, glioma, migration, proliferation, cancer, signaling, polycystic kidney disease |
 |
FULLER |
CATHERINE |
ENaC/ASIC Ion Channels; |
Sodium channels, glioma, migration, proliferation, cancer, signaling, polycystic kidney disease |
 |
FULLER |
CATHERINE |
ENaC/ASIC Ion Channels; |
Sodium channels, glioma, migration, proliferation, cancer, signaling, polycystic kidney disease |
 |
FULLER |
CATHERINE |
ENaC/ASIC Ion Channels; |
Sodium channels, glioma, migration, proliferation, cancer, signaling, polycystic kidney disease |
 |
FULLER |
CATHERINE |
ENaC/ASIC Ion Channels; |
Sodium channels, glioma, migration, proliferation, cancer, signaling, polycystic kidney disease |
 |
FULLER |
CATHERINE |
ENaC/ASIC Ion Channels; |
Sodium channels, glioma, migration, proliferation, cancer, signaling, polycystic kidney disease |
 |
FULLER |
CATHERINE |
ENaC/ASIC Ion Channels; |
Sodium channels, glioma, migration, proliferation, cancer, signaling, polycystic kidney disease |
 |
FULLER |
CATHERINE |
ENaC/ASIC Ion Channels; |
Sodium channels, glioma, migration, proliferation, cancer, signaling, polycystic kidney disease |
 |
FULLER |
CATHERINE |
ENaC/ASIC Ion Channels; |
Sodium channels, glioma, migration, proliferation, cancer, signaling, polycystic kidney disease |
 |
FULLER |
CATHERINE |
ENaC/ASIC Ion Channels; |
Sodium channels, glioma, migration, proliferation, cancer, signaling, polycystic kidney disease |
 |
FULLER |
CATHERINE |
ENaC/ASIC Ion Channels; |
Sodium channels, glioma, migration, proliferation, cancer, signaling, polycystic kidney disease |
 |
FULLER |
CATHERINE |
ENaC/ASIC Ion Channels; |
Sodium channels, glioma, migration, proliferation, cancer, signaling, polycystic kidney disease |
 |
FULLER |
CATHERINE |
ENaC/ASIC Ion Channels; |
Sodium channels, glioma, migration, proliferation, cancer, signaling, polycystic kidney disease |
 |
FULLER |
CATHERINE |
ENaC/ASIC Ion Channels; |
Sodium channels, glioma, migration, proliferation, cancer, signaling, polycystic kidney disease |
 |
FULLER |
CATHERINE |
ENaC/ASIC Ion Channels; |
Sodium channels, glioma, migration, proliferation, cancer, signaling, polycystic kidney disease |
 |
FULLER |
CATHERINE |
ENaC/ASIC Ion Channels; |
Sodium channels, glioma, migration, proliferation, cancer, signaling, polycystic kidney disease |
 |
FULLER |
CATHERINE |
ENaC/ASIC Ion Channels; |
Sodium channels, glioma, migration, proliferation, cancer, signaling, polycystic kidney disease |
 |
FULLER |
CATHERINE |
ENaC/ASIC Ion Channels; |
Sodium channels, glioma, migration, proliferation, cancer, signaling, polycystic kidney disease |
 |
FULLER |
CATHERINE |
ENaC/ASIC Ion Channels; |
Sodium channels, glioma, migration, proliferation, cancer, signaling, polycystic kidney disease |
 |
FULLER |
CATHERINE |
ENaC/ASIC Ion Channels; |
Sodium channels, glioma, migration, proliferation, cancer, signaling, polycystic kidney disease |
 |
FULLER |
CATHERINE |
ENaC/ASIC Ion Channels; |
Sodium channels, glioma, migration, proliferation, cancer, signaling, polycystic kidney disease |
 |
FULLER |
CATHERINE |
ENaC/ASIC Ion Channels; |
Sodium channels, glioma, migration, proliferation, cancer, signaling, polycystic kidney disease |
 |
FULLER |
CATHERINE |
ENaC/ASIC Ion Channels; |
Sodium channels, glioma, migration, proliferation, cancer, signaling, polycystic kidney disease |
 |
FULLER |
CATHERINE |
ENaC/ASIC Ion Channels; |
Sodium channels, glioma, migration, proliferation, cancer, signaling, polycystic kidney disease |
 |
GALIN |
F. |
Neuroimmunology/Multiple Sclerosis |
|
 |
GALIN |
F. |
Neuroimmunology/Multiple Sclerosis |
|
 |
GALIN |
F. |
Neuroimmunology/Multiple Sclerosis |
|
 |
GALIN |
F. |
Neuroimmunology/Multiple Sclerosis |
|
 |
GALIN |
F. |
Neuroimmunology/Multiple Sclerosis |
|
 |
GALIN |
F. |
Neuroimmunology/Multiple Sclerosis |
|
 |
GALIN |
F. |
Neuroimmunology/Multiple Sclerosis |
|
 |
GALIN |
F. |
Neuroimmunology/Multiple Sclerosis |
|
 |
GAMLIN |
PAUL |
Studies of the Neural Bases of Vision & Eye Movements |
pupil, vergence, gene therapy, fMRI |
 |
GAMLIN |
PAUL |
Studies of the Neural Bases of Vision & Eye Movements |
pupil, vergence, gene therapy, fMRI |
 |
GAMLIN |
PAUL |
Studies of the Neural Bases of Vision & Eye Movements |
pupil, vergence, gene therapy, fMRI |
 |
GAMLIN |
PAUL |
Studies of the Neural Bases of Vision & Eye Movements |
pupil, vergence, gene therapy, fMRI |
 |
GAMLIN |
PAUL |
Studies of the Neural Bases of Vision & Eye Movements |
pupil, vergence, gene therapy, fMRI |
 |
GAMLIN |
PAUL |
Studies of the Neural Bases of Vision & Eye Movements |
pupil, vergence, gene therapy, fMRI |
 |
GAMLIN |
PAUL |
Studies of the Neural Bases of Vision & Eye Movements |
pupil, vergence, gene therapy, fMRI |
 |
GAMLIN |
PAUL |
Studies of the Neural Bases of Vision & Eye Movements |
pupil, vergence, gene therapy, fMRI |
 |
GAMLIN |
PAUL |
Studies of the Neural Bases of Vision & Eye Movements |
pupil, vergence, gene therapy, fMRI |
 |
GAMLIN |
PAUL |
Studies of the Neural Bases of Vision & Eye Movements |
pupil, vergence, gene therapy, fMRI |
 |
GAMLIN |
PAUL |
Studies of the Neural Bases of Vision & Eye Movements |
pupil, vergence, gene therapy, fMRI |
 |
GAMLIN |
PAUL |
Studies of the Neural Bases of Vision & Eye Movements |
pupil, vergence, gene therapy, fMRI |
 |
GAMLIN |
PAUL |
Studies of the Neural Bases of Vision & Eye Movements |
pupil, vergence, gene therapy, fMRI |
 |
GAMLIN |
PAUL |
Studies of the Neural Bases of Vision & Eye Movements |
pupil, vergence, gene therapy, fMRI |
 |
GAMLIN |
PAUL |
Studies of the Neural Bases of Vision & Eye Movements |
pupil, vergence, gene therapy, fMRI |
 |
GAMLIN |
PAUL |
Studies of the Neural Bases of Vision & Eye Movements |
pupil, vergence, gene therapy, fMRI |
 |
GAMLIN |
PAUL |
Studies of the Neural Bases of Vision & Eye Movements |
pupil, vergence, gene therapy, fMRI |
 |
GAMLIN |
PAUL |
Studies of the Neural Bases of Vision & Eye Movements |
pupil, vergence, gene therapy, fMRI |
 |
GAMLIN |
PAUL |
Studies of the Neural Bases of Vision & Eye Movements |
pupil, vergence, gene therapy, fMRI |
 |
GAMLIN |
PAUL |
Studies of the Neural Bases of Vision & Eye Movements |
pupil, vergence, gene therapy, fMRI |
 |
GAMLIN |
PAUL |
Studies of the Neural Bases of Vision & Eye Movements |
pupil, vergence, gene therapy, fMRI |
 |
GAMLIN |
PAUL |
Studies of the Neural Bases of Vision & Eye Movements |
pupil, vergence, gene therapy, fMRI |
 |
GAMLIN |
PAUL |
Studies of the Neural Bases of Vision & Eye Movements |
pupil, vergence, gene therapy, fMRI |
 |
GAMLIN |
PAUL |
Studies of the Neural Bases of Vision & Eye Movements |
pupil, vergence, gene therapy, fMRI |
 |
GAMLIN |
PAUL |
Studies of the Neural Bases of Vision & Eye Movements |
pupil, vergence, gene therapy, fMRI |
 |
GAMLIN |
PAUL |
Studies of the Neural Bases of Vision & Eye Movements |
pupil, vergence, gene therapy, fMRI |
 |
GAMLIN |
PAUL |
Studies of the Neural Bases of Vision & Eye Movements |
pupil, vergence, gene therapy, fMRI |
 |
GAMLIN |
PAUL |
Studies of the Neural Bases of Vision & Eye Movements |
pupil, vergence, gene therapy, fMRI |
 |
GAMLIN |
PAUL |
Studies of the Neural Bases of Vision & Eye Movements |
pupil, vergence, gene therapy, fMRI |
 |
GAMLIN |
PAUL |
Studies of the Neural Bases of Vision & Eye Movements |
pupil, vergence, gene therapy, fMRI |
 |
GAMLIN |
PAUL |
Studies of the Neural Bases of Vision & Eye Movements |
pupil, vergence, gene therapy, fMRI |
 |
GAMLIN |
PAUL |
Studies of the Neural Bases of Vision & Eye Movements |
pupil, vergence, gene therapy, fMRI |
 |
GAMLIN |
PAUL |
Studies of the Neural Bases of Vision & Eye Movements |
pupil, vergence, gene therapy, fMRI |
 |
GAMLIN |
PAUL |
Studies of the Neural Bases of Vision & Eye Movements |
pupil, vergence, gene therapy, fMRI |
 |
GAMLIN |
PAUL |
Studies of the Neural Bases of Vision & Eye Movements |
pupil, vergence, gene therapy, fMRI |
 |
GARVEY |
W. |
Molecular and physiological pathogenesis of human insulin resistance |
Insulin resistance, obesity, Metabolic Syndrome, Type 2 Diabetes |
 |
GARVEY |
W. |
Molecular and physiological pathogenesis of human insulin resistance |
Insulin resistance, obesity, Metabolic Syndrome, Type 2 Diabetes |
 |
GARVEY |
W. |
Molecular and physiological pathogenesis of human insulin resistance |
Insulin resistance, obesity, Metabolic Syndrome, Type 2 Diabetes |
 |
GARVEY |
W. |
Molecular and physiological pathogenesis of human insulin resistance |
Insulin resistance, obesity, Metabolic Syndrome, Type 2 Diabetes |
 |
GARVEY |
W. |
Molecular and physiological pathogenesis of human insulin resistance |
Insulin resistance, obesity, Metabolic Syndrome, Type 2 Diabetes |
 |
GARVEY |
W. |
Molecular and physiological pathogenesis of human insulin resistance |
Insulin resistance, obesity, Metabolic Syndrome, Type 2 Diabetes |
 |
GARVEY |
W. |
Molecular and physiological pathogenesis of human insulin resistance |
Insulin resistance, obesity, Metabolic Syndrome, Type 2 Diabetes |
 |
GARVEY |
W. |
Molecular and physiological pathogenesis of human insulin resistance |
Insulin resistance, obesity, Metabolic Syndrome, Type 2 Diabetes |
 |
GARVEY |
W. |
Molecular and physiological pathogenesis of human insulin resistance |
Insulin resistance, obesity, Metabolic Syndrome, Type 2 Diabetes |
 |
GARVEY |
W. |
Molecular and physiological pathogenesis of human insulin resistance |
Insulin resistance, obesity, Metabolic Syndrome, Type 2 Diabetes |
 |
GARVEY |
W. |
Molecular and physiological pathogenesis of human insulin resistance |
Insulin resistance, obesity, Metabolic Syndrome, Type 2 Diabetes |
 |
GARVEY |
W. |
Molecular and physiological pathogenesis of human insulin resistance |
Insulin resistance, obesity, Metabolic Syndrome, Type 2 Diabetes |
 |
GAWNE |
TIMOTHY |
Information Processing in the Central Nervous System |
EEG, MEG, myopia, schizophrenia, cerebral cortex, vision, retina |
 |
GAWNE |
TIMOTHY |
Information Processing in the Central Nervous System |
EEG, MEG, myopia, schizophrenia, cerebral cortex, vision, retina |